June 8, 2017 - By Vivian Park
Corindus Vascular Robotics Incorporated (NYSEMKT:CVRS) had an increase of 2.99% in short interest. CVRS’s SI was 7.58M shares in June as released by FINRA. Its up 2.99% from 7.36 million shares previously. With 508,600 avg volume, 15 days are for Corindus Vascular Robotics Incorporated (NYSEMKT:CVRS)’s short sellers to cover CVRS’s short positions. The SI to Corindus Vascular Robotics Incorporated’s float is 24.99%. It closed at $1.24 lastly. It is down 8.65% since June 8, 2016 and is uptrending. It has underperformed by 8.05% the S&P500.
Stanley-Laman Group Ltd decreased U S Concrete Inc (USCR) stake by 57.64% reported in 2016Q4 SEC filing. Stanley-Laman Group Ltd sold 12,256 shares as U S Concrete Inc (USCR)’s stock rose 9.29%. The Stanley-Laman Group Ltd holds 9,007 shares with $590,000 value, down from 21,263 last quarter. U S Concrete Inc now has $1.12 billion valuation. It closed at $69.15 lastly. It is down 14.26% since June 8, 2016 and is uptrending. It has underperformed by 2.44% the S&P500.
Since December 12, 2016, it had 0 insider buys, and 12 insider sales for $3.88 million activity. $17,725 worth of US Concrete Inc (NASDAQ:USCR) shares were sold by Kohutek Kevin. $397,638 worth of US Concrete Inc (NASDAQ:USCR) shares were sold by DAVIS JEFF L. Peabody Mark Baker had sold 3,000 shares worth $209,507. $444,862 worth of US Concrete Inc (NASDAQ:USCR) was sold by SANDBROOK WILLIAM J. On Friday, June 2 ROBERTS JEFFREY W sold $162,792 worth of US Concrete Inc (NASDAQ:USCR) or 2,394 shares. The insider POULSEN NIEL L sold 12,957 shares worth $906,990. Sutherland Colin McGill also sold $12,740 worth of US Concrete Inc (NASDAQ:USCR) on Monday, December 12.
Among 4 analysts covering U.S. Concrete (NASDAQ:USCR), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. U.S. Concrete had 5 analyst reports since November 24, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, November 24 by Sidoti. The firm has “Buy” rating by DA Davidson given on Thursday, June 9. The rating was initiated by Citigroup with “Neutral” on Tuesday, December 15. The rating was downgraded by Sidoti to “Neutral” on Wednesday, April 20. The rating was initiated by BB&T Capital with “Buy” on Thursday, April 21.
Investors sentiment increased to 1.28 in 2016 Q4. Its up 0.26, from 1.02 in 2016Q3. It improved, as 23 investors sold USCR shares while 60 reduced holdings. 43 funds opened positions while 63 raised stakes. 17.11 million shares or 7.47% more from 15.93 million shares in 2016Q3 were reported. Suffolk Capital Management Limited Liability has 0.2% invested in US Concrete Inc (NASDAQ:USCR). Legal & General Gru Public Limited Company, United Kingdom-based fund reported 23,572 shares. Lpl Financial Limited Liability Corporation has 0% invested in US Concrete Inc (NASDAQ:USCR). Credit Suisse Ag stated it has 0% in US Concrete Inc (NASDAQ:USCR). Blackrock Group Incorporated holds 26,386 shares or 0% of its portfolio. Arrowpoint Asset Management Limited Liability Corporation invested in 0.08% or 76,000 shares. Fortress Invest Grp Llc accumulated 0.01% or 5,815 shares. Alliancebernstein LP has invested 0% in US Concrete Inc (NASDAQ:USCR). Rbf Capital Limited Liability accumulated 5,211 shares. 96,079 were reported by Federated Invsts Inc Pa. Tocqueville Asset Mngmt Ltd Partnership reported 313,615 shares or 0.26% of all its holdings. Metropolitan Life Com New York stated it has 0% in US Concrete Inc (NASDAQ:USCR). Wells Fargo Company Mn has invested 0% in US Concrete Inc (NASDAQ:USCR). Independent Port Consultants Incorporated holds 0.01% of its portfolio in US Concrete Inc (NASDAQ:USCR) for 275 shares. Next Century Growth Investors owns 565,261 shares for 2.27% of their portfolio.
Stanley-Laman Group Ltd increased Union Pacific Corp (NYSE:UNP) stake by 8,553 shares to 21,110 valued at $2.19M in 2016Q4. It also upped Alliance Data System (NYSE:ADS) stake by 6,118 shares and now owns 11,466 shares. Intel Corp (NASDAQ:INTC) was raised too.
Corindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The company has market cap of $230.12 million. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. It currently has negative earnings. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.